Friday, September 3, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Areas
Cover Stories
Transformers
Pfizer is undergoing a transformation. Since the failure of its promising pill Torcetrapib, all of Pfizer’s operating divisions have been...
Pandemic preparedness
In April 2007, the FDA announced the first approval in the US of a vaccine for humans against the H5N1 influenza virus. Its manufacturer,...
The best of both
In January 2007, Merck Serono was launched as a subsidiary of Merck KGaA.
Roundtables
-
Protecting pharmaceutical products
The incidence of counterfeit drugs in Europe is increasing. With seizures of fake or substandard drugs topping 2.7 million items, Authentix, Mondi Packaging and SICPA sat...Read more
Vendor Perspectives
-
Early phase communication planning – why...
The moment you have something to say about your product you have begun the communication process. And you have created the first impression of your product. Often, this is...Read more -
Randox Laboratories Ltd – from bench to ...
Randox Laboratories is the leading manufacturer of diagnostic products in the UK and one of the fastest growing clinical diagnostic companies in the world, ranking 23rd in...Read more -
The use of biomarkers and surrogate endp...
By Tomasz Burzykowski, Sr. Statistician MSOURCE and Associate Prof at the University of HasseltRead more -
Cutting edge on pharmaceutical filling a...
Bosch Pharma, a company of Bosch Packaging Technology, is a specialist in the pharmaceutical production and packaging sector.Read more
Industry Analysts
-
Forward-thinking informatics
Jennifer Allerton, Chief Information Officer for Roche Pharma shares her thoughts on the importance of informatics in the industry.Read more -
Are you keeping an eye on your products?
NGP asked Dr. Jörg-Peter Conzen, Vice President of Bruker Optics, why Near-Infrared (NIR) spectroscopy is a valuable tool for the pharmaceutical industry.Read more -
Lentiviral vectors: from research to gene ...
Boro Dropulic, Founder and CEO of Lentigen Corporation, about highly efficient and stable gene delivery offered by Lentiviral vectors.Read more -
Behavioural pharmacology
MPI Research’s Dr. David Gauvin discusses predictive methodologies to identify and characterise potential abuse liability issues.Read more
Executive Interviews
Automated blood sampling
NGP asked DiLab’s Per Dannhusen what to bear in mind when switching to automated blood sampling.
Read more
Expanding into biotherapeutics
Biotherapeutics, believes Dr. Tim Riley, Vice President and Managing Director of the Pharmaceutical Business Operations at Waters Corporation, is rapidly growing. NGP asked him how Water’s mass spectrometry systems help to characterise these thera...
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.